Michael Islek - ICoreConnect Common Chief Advisor
| ICCT Stock | USD 0.19 0.03 13.64% |
Insider
Michael Islek is Chief Advisor of iCoreConnect Common stock
| Address | 529 East Crown Point Road, Ocoee, FL, United States, 34761 |
| Phone | 888 810 7706 |
| Web | https://www.icoreconnect.com |
ICoreConnect Common Management Efficiency
The company has return on total asset (ROA) of (0.6589) % which means that it has lost $0.6589 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.4246) %, meaning that it created substantial loss on money invested by shareholders. ICoreConnect Common's management efficiency ratios could be used to measure how well ICoreConnect Common manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.58 in 2024. Return On Capital Employed is likely to gain to -1.43 in 2024. At this time, ICoreConnect Common's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 788.4 K in 2024, whereas Total Current Liabilities is likely to drop slightly above 5.7 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Christian Arnell | So Young International | N/A | |
| Pr BBSc | Cogstate Limited | N/A | |
| Xing Jin | So Young International | 44 | |
| Jessica Somers | Evolent Health | N/A | |
| Tao Yu | So Young International | 45 | |
| Rui Cai | So Young International | N/A | |
| Craig Barbarosh | Evolent Health | 52 | |
| Michael Howe | Mitesco | 70 | |
| Christopher Kohler | Scworx Corp | 43 | |
| Benjamin Bloomfield | Cogstate Limited | N/A | |
| Lawrence Diamond | Mitesco | 59 | |
| Kenneth Billard | Cogstate Limited | N/A | |
| Jenny Lindstrom | Mitesco | 49 | |
| Susan MD | Healthcare Integrated Technolog | 59 | |
| Rachel Colite | Cogstate Limited | N/A | |
| Peter Grua | Evolent Health | 66 | |
| Kali Beyah | Evolent Health | N/A | |
| M Duffy | Evolent Health | 61 | |
| MAAA FSA | Evolent Health | 51 | |
| BBus CA | Cogstate Limited | N/A | |
| Thomas Brodmerkel | Mitesco | 65 | |
Management Performance
| Return On Equity | -10.42 | ||||
| Return On Asset | -0.66 |
iCoreConnect Common stock Leadership Team
Elected by the shareholders, the ICoreConnect Common's board of directors comprises two types of representatives: ICoreConnect Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ICoreConnect. The board's role is to monitor ICoreConnect Common's management team and ensure that shareholders' interests are well served. ICoreConnect Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ICoreConnect Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Muralidar Chakravarthi, Chief Officer | ||
| David Fidanza, Chief Officer | ||
| Cile Spelce, Chief Officer | ||
| Michael Islek, Chief Advisor | ||
| Alyse Fidanza, Secretary | ||
| Stacey Trottier, Vice Sales | ||
| Archit Shah, Chief Officer | ||
| Robert McDermott, President CEO, Director | ||
| Chris Elley, Chief Officer | ||
| Jeffrey Stellinga, COO Director |
ICoreConnect Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ICoreConnect Common a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -10.42 | ||||
| Return On Asset | -0.66 | ||||
| Profit Margin | (2.61) % | ||||
| Operating Margin | (0.88) % | ||||
| Current Valuation | 16.45 M | ||||
| Shares Outstanding | 24.32 M | ||||
| Shares Owned By Insiders | 33.45 % | ||||
| Shares Owned By Institutions | 9.10 % | ||||
| Number Of Shares Shorted | 107.85 K | ||||
| Price To Book | 8.91 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ICoreConnect Stock Analysis
When running ICoreConnect Common's price analysis, check to measure ICoreConnect Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICoreConnect Common is operating at the current time. Most of ICoreConnect Common's value examination focuses on studying past and present price action to predict the probability of ICoreConnect Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICoreConnect Common's price. Additionally, you may evaluate how the addition of ICoreConnect Common to your portfolios can decrease your overall portfolio volatility.